|
1
|
Lee B, Godfrey M, Vitale E, Hori H, Mattei
MG, Sarfarazi M, Tsipouras P, Ramirez F and Hollister DW: Linkage
of Marfan syndrome and a phenotypically related disorder to two
different fibrillin genes. Nature. 352:330–334. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klimstra WB, Heidner HW and Johnston RE:
The furin protease cleavage recognition sequence of Sindbis virus
PE2 can mediate virion attachment to cell surface heparan sulfate.
J Virol. 73:6299–6306. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Romere C, Duerrschmid C, Bournat J,
Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B, et
al: Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell.
165:566–579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Neill B, Simha V, Kotha V and Garg A:
Body fat distribution and metabolic variables in patients with
neonatal progeroid syndrome. Am J Med Genet A. 143A:1421–1430.
2007. View Article : Google Scholar
|
|
5
|
Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen
Y, Zheng Y and Zheng H: Plasma Asprosin Concentrations Are
Increased in Individuals with Glucose Dysregulation and Correlated
with Insulin Resistance and First-Phase Insulin Secretion.
Mediators Inflamm. 2018:94715832018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Liao M, Shen R, Zhang L, Hu H, Wu J,
Wang X, Qu H, Guo S, Long M, et al: Plasma Asprosin Levels Are
Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles
in Females with Metabolic-Related Diseases. Mediators Inflamm.
2018:73752942018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang CY, Lin TA, Liu KH, Liao CH, Liu YY,
Wu VCC, Wen MS and Yeh TS: Serum asprosin levels and bariatric
surgery outcomes in obese adults. Int J Obes. 43:1019–1025. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du C, Wang C, Guan X, Li J, Du X, Xu Z, Li
B, Liu Y, Fu F, Huo H, et al: Asprosin is associated with anorexia
and body fat mass in cancer patients. Support Care Cancer.
29:1369–1375. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duerrschmid C, He Y, Wang C, Li C, Bournat
JC, Romere C, Saha PK, Lee ME, Phillips KJ, Jain M, et al: Asprosin
is a centrally acting orexigenic hormone. Nat Med. 23:1444–1453.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Jiang H, Ma X and Wu H: Increased
serum level and impaired response to glucose fluctuation of
asprosin is associated with type 2 diabetes mellitus. J Diabetes
Investig. 11:349–355. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li E, Shan H, Chen L, Long A, Zhang Y, Liu
Y, Jia L, Wei F, Han J, Li T, et al: OLFR734 Mediates Glucose
Metabolism as a Receptor of Asprosin. Cell Metab. 30:319–328.e8.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kerslake R, Hall M, Randeva HS, Spandidos
DA, Chatha K, Kyrou I and Karteris E: Co expression of peripheral
olfactory receptors with SARS CoV 2 infection mediators: Potential
implications beyond loss of smell as a COVID 19 symptom. Int J Mol
Med. 46:949–956. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei F, Long A and Wang Y: The
Asprosin-OLFR734 Hormonal Signaling Axis Modulates Male Fertility.
Cell Discov. 5:552019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maylem ERS, Spicer LJ, Batalha I and
Schutz LF: Discovery of a possible role of asprosin in ovarian
follicular function. J Mol Endocrinol. 66:35–44. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao W, Ho L, Varghese M, Yemul S,
Dams-O'Connor K, Gordon W, Knable L, Freire D, Haroutunian V and
Pasinetti GM: Decreased level of olfactory receptors in blood cells
following traumatic brain injury and potential association with
tauopathy. J Alzheimers Dis. 34:417–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prodoehl MJ, Hatzirodos N, Irving-Rodgers
HF, Zhao ZZ, Painter JN, Hickey TE, Gibson MA, Rainey WE, Carr BR,
Mason HD, et al: Genetic and gene expression analyses of the
polycystic ovary syndrome candidate gene fibrillin-3 and other
fibrillin family members in human ovaries. Mol Hum Reprod.
15:829–841. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Liu Y, Lu L, Yang L, Yin S, Wang
Y, Qi Z, Meng J, Zang R and Yang G: Fibrillin-1, induced by
Aurora-A but inhibited by BRCA2, promotes ovarian cancer
metastasis. Oncotarget. 6:6670–6683. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Millstein J, Budden T, Goode EL, Anglesio
MS, Talhouk A, Intermaggio MP, Leong HS, Chen S, Elatre W, Gilks B,
et al AOCS Group, : Prognostic gene expression signature for
high-grade serous ovarian cancer. Ann Oncol. 31:1240–1250. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kellenberger LD and Petrik J:
Hyperglycemia promotes insulin-independent ovarian tumor growth.
Gynecol Oncol. 149:361–370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg R A: Hallmarks of
Cancer: The next Generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cantuaria G, Fagotti A, Ferrandina G,
Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S and Scambia
G: GLUT-1 expression in ovarian carcinoma: Association with
survival and response to chemotherapy. Cancer. 92:1144–1150. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saravi S, Katsuta E, Jeyaneethi J, Amin
HA, Kaspar M, Takabe K, Pados G, Drenos F, Hall M and Karteris E:
H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer
and Demonstrates Utility as a Prognostic Biomarker in Terms of
Overall Survival. J Clin Med. 9:28442020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo Q, Song Y, Zhang H, Wu X, Xia P and
Dang C: Detection of Hypermethylated Fibrillin-1 in the Stool
Samples of Colorectal Cancer Patients. Med Oncol. 30:6952013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu CW, Wang JC, Liao WI, Chien WC, Chung
CH, Tsao CH, Wu YF, Liao MT and Tsai SH: Association between
malignancies and Marfan syndrome: A population-based, nested
case-control study in Taiwan. BMJ Open. 7:e0172432017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Naba A, Clauser KR, Mani DR, Carr SA and
Hynes RO: Quantitative proteomic profiling of the extracellular
matrix of pancreatic islets during the angiogenic switch and
insulinoma progression. Sci Rep. 7:404952017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Summers KM, Bokil NJ, Baisden JM, West MJ,
Sweet MJ, Raggatt LJ and Hume DA: Experimental and bioinformatic
characterisation of the promoter region of the Marfan syndrome
gene, FBN1. Genomics. 94:233–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
De Koning DJ and Haley CS: Genetical
Genomics in Humans and Model Organisms. Genetical genomics in
humans and model organisms. Trends Genet. 21:377–381. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hubner N, Wallace CA, Zimdahl H, Petretto
E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, et
al: Integrated transcriptional profiling and linkage analysis for
identification of genes underlying disease. Nat Genet. 37:243–253.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liberti MV and Locasale JW: The Warburg
Effect: How Does It Benefit Cancer Cells? Trends Biochem Sci.
41:211–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong D, Dong Y, Fu J, Lu S, Yuan C, Xia M
and Sun L: Bcl2 inhibitor ABT737 reverses the Warburg effect via
the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis
in ovarian cancer cells. Life Sci. 255:117846. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li WH, Zhang H, Guo Q, Wu XD, Xu ZS, Dang
CX, Xia P and Song YC: Detection of SNCA and FBN1 methylation in
the stool as a biomarker for colorectal cancer. Dis Markers.
2015:6575702015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen J, Cai Y, Xu R, Pan J, Zhou J and Mei
J, Zhou J and Mei J: Identification of four hub genes as promising
biomarkers to evaluate the prognosis of ovarian cancer in silico.
Cancer Cell Int. 20:2702020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mo X, Su Z, Yang B, Zeng Z, Lei S and Qiao
H: Identification of key genes involved in the development and
progression of early-onset colorectal cancer by co-expression
network analysis. Oncol Lett. 19:177–186. 2020.PubMed/NCBI
|
|
37
|
Shi S and Tian B: Identification of
biomarkers associated with progression and prognosis in bladder
cancer via co-expression analysis. Cancer Biomark. 24:183–193.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhai X, Xue Q, Liu Q, Guo Y and Chen Z:
Colon cancer recurrence associated genes revealed by WGCNA co
expression network analysis. Mol Med Rep. 16:6499–6505. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kellenberger LD, Bruin JE, Greenaway J,
Campbell NE, Moorehead RA, Holloway AC and Petrik J: The role of
dysregulated glucose metabolism in epithelial ovarian cancer. J
Oncol. 2010:5143102010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aran D, Camarda R, Odegaard J, Paik H,
Oskotsky B, Krings G, Goga A, Sirota M and Butte AJ: Comprehensive
analysis of normal adjacent to tumor transcriptomes. Nat Commun.
8:10772017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kocaman N and Artaş G: Can novel
adipokines, asprosin and meteorin-like, be biomarkers for malignant
mesothelioma? Biotech Histochem. 95:171–175. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rajagopal S and Shenoy SK: GPCR
desensitization: Acute and prolonged phases. Cell Signal. 41:9–16.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Karteris E and Randeva HS: Orexin
Receptors and G-Protein Coupling: Evidence for Another
‘Promiscuous’ Seven Transmembrane Domain Receptor. J Pharmacol Sci.
93:126–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee T, Yun S, Jeong JH and Jung TW:
Asprosin impairs insulin secretion in response to glucose and
viability through TLR4/JNK-mediated inflammation. Mol Cell
Endocrinol. 486:96–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zandi Z, Kashani B, Poursani EM, Bashash
D, Kabuli M, Momeny M, Mousavi-Pak SH, Sheikhsaran F, Alimoghaddam
K, Mousavi SA, et al: TLR4 blockade using TAK-242 suppresses
ovarian and breast cancer cells invasion through the inhibition of
extracellular matrix degradation and epithelial-mesenchymal
transition. Eur J Pharmacol. 853:256–263. 2019. View Article : Google Scholar : PubMed/NCBI
|
